Patent US4579686A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4579686A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the preparation of easy-flowing (flowable) oxytetracyclin hydrochloride

Assignee: Teva Pharmaceutical Works PLC
•
Filing: 1984-05-02
•
Granted: 1986-04-01
•
Expires: 2004-05-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to a new process for the preparation of easy-flowing (flowable) oxytetracyclin hydrochloride. According to the process of the invention, the crude, dry or filter-wet oxytetracyclin hydrochloride consisting of needle-shaped crystals is boiled with an organic solvent forming an azeotropic mixture with water, optionally a part of the solvent is distilled off in a form of an azeotropic mixture, then the mixture is cooled and the precipitated oxytetracyclin hydrochloride consisting of spherical crystals is separated and dried. Oxytetracyclin hydrochloride exists in two various crystal forms, the one of which is needle-shaped, while the other one consists of orthorhombic sheets. The crystals of this latter form are capable of forming spherical particles by coalescence. The crystal form consisting of spherical particles is much more useful for the pharmaceutical industry. By means of the new process easy-flowing (flowable) oxytetracyclin hydrochloride can be prepared in a favorable yield and with a high purity from the crude hydrochloride product consisting of needle-shaped crystals.

Inventors

  • 👤 Miklos Szarvas
  • 👤 Eva Horvath nee Feher
  • 👤 Laszlo Cseke
  • 👤 Janos Balint
  • 👤 Ferenc Fabian
  • 👤 Lajos Kun

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 17:09
CPC Classifications
C; C07; C07C; C07C41/00; C07C41/01; C07C41/34; C07C233/00

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 166 words
A process for the preparation of flowable oxytetracycline hydrochloride in the form of spherical crystals which comprises the steps of: (a) suspending a dried or filter-wet crude oxytetracycline hydrochloride in the form of needle-shaped crystals containing water in an organic solvent consisting of a C 1 -C 4 alkyl ester of acetic acid; (b) boiling the suspension formed in step (a) to form both a precipitate of oxytetracycline hydrochloride in the form of spherical crystals and an azeotropic mixture of the organic solvent and water, said water being the water present initially in the crude oxytetracycline hydrochloride in the form of needle-shaped crystals; (c) cooling the precipitate of oxytetracycline hydrochloride in the form of spherical crystals and the azeotropic mixture of the organic solvent and water to room temperature; (d) separating the oxytetracyline hydrochloride in the form of spherical crystals from the azeotropic mixture; and (e) drying the oxytetracycline hydrochloride in the form of spherical crystals so that the water content thereof is less than 1%.
Claim 2
Dependent Claim 166 words
A process for the preparation of flowable oxytetracycline hydrochloride in the form of spherical crystals which comprises the steps of: (a) suspending a dried or filter-wet crude oxytetracycline hydrochloride in the form of needle-shaped crystals containing water in an organic solvent consisting of a C 1 -C 4 alkyl ester of acetic acid; (b) boiling the suspension formed in step (a) to form both a precipitate of oxytetracycline hydrochloride in the form of spherical crystals and an azeotropic mixture of the organic solvent and water, said water being the water present initially in the crude oxytetracycline hydrochloride in the form of needle-shaped crystals; (c) cooling the precipitate of oxytetracycline hydrochloride in the form of spherical crystals and the azeotropic mixture of the organic solvent and water to room temperature; (d) separating the oxytetracyline hydrochloride in the form of spherical crystals from the azeotropic mixture; and (e) drying the oxytetracycline hydrochloride in the form of spherical crystals so that the water content thereof is less than 1%.
Claim 3
Dependent Claim 25 words
The process defined in claim 1 wherein following step (b) at least part of the azeotropic mixture of organic solvent and water is distilled off.
Claim 4
Dependent Claim 24 words
The process defined in claim 2 wherein the oxytetracycline hydrochloride thus obtained in the form of spherical crystals has a water content of 0.2%.

References Cited (Backward Citations)

US2516080A Cited
GB718020A Cited
US2658078A Cited
GB718027A Cited
GB718032A Cited
US2867661A Cited
US2929837A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-03-31 1989-09-30 1990-04-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-03-31 1993-09-30 1994-04-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-03-31 1997-09-30 1998-04-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag